Robotic-Assisted Rehabilitation for Stroke
Trial Summary
What is the purpose of this trial?
Stroke is the third leading cause of death and the primary cause of long-term disability in the United States, affecting approximately 795,000 people each year. Hemiparesis, or unilateral weakness, is common after stroke and responsible for changes in muscle activation and movement patterns as well as declines in walking speed. It has been shown that increased walking speed directly corresponds to a higher quality of life in older adults and therefore, is often the goal of motor rehabilitation after stroke. However, there is no consensus on the best method for improving walking function after stroke and the results of post-stroke gait studies vary widely across sites and studies. Walking is one of the human's most important functions that serve survival, progress, and interaction. The force between the foot and the walking surface is very important. Although there have been many studies trying to understand this, there is a need for the development of a system that can advance research and provide new functionality. In this work, we will conduct a series of studies that attempt to analyze human gait and adaptations from different perspectives.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to get a clear answer.
What data supports the effectiveness of the treatment Robotic-Assisted Rehabilitation for Stroke?
Research suggests that robot-assisted treadmill training can be beneficial for stroke rehabilitation by improving muscle activity and gait patterns. The Variable Stiffness Treadmill, a type of robotic treadmill, has shown promising results in increasing step length and improving gait in healthy subjects, which may be useful for post-stroke rehabilitation.12345
Is robotic-assisted rehabilitation for stroke generally safe for humans?
Robotic-assisted rehabilitation, including devices like stationary gait robots, is generally safe but can cause some adverse events (unwanted effects). These include skin and tissue injuries, musculoskeletal issues, and changes in blood pressure, often due to pressure and misalignment between the robot and the human body. More detailed reporting and safety measures are needed to further improve safety.13678
How does robotic-assisted rehabilitation for stroke differ from other treatments?
Eligibility Criteria
This trial is for adults aged 18-80 who are in good health or have had a single stroke over 6 months ago. Healthy participants must pass a fitness questionnaire, while stroke survivors need to walk unassisted for 15 minutes and have their condition confirmed by MRI or CT scan. All must speak English, weigh under 250 lbs, and have stable heart rates and blood pressure.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a series of studies analyzing human gait and adaptations using robotics and neuromuscular modeling
Follow-up
Participants are monitored for safety and effectiveness after intervention
Treatment Details
Interventions
- Belt Accelerations
- Belt accelerations combined with an exoskeleton
- Variable Stiffness treadmill
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Delaware
Lead Sponsor